KR20000065178A - 허혈-재관류손상을치료또는예방하는방법 - Google Patents

허혈-재관류손상을치료또는예방하는방법 Download PDF

Info

Publication number
KR20000065178A
KR20000065178A KR1019980708806A KR19980708806A KR20000065178A KR 20000065178 A KR20000065178 A KR 20000065178A KR 1019980708806 A KR1019980708806 A KR 1019980708806A KR 19980708806 A KR19980708806 A KR 19980708806A KR 20000065178 A KR20000065178 A KR 20000065178A
Authority
KR
South Korea
Prior art keywords
ischemia
reperfusion injury
healing
aortic
patients
Prior art date
Application number
KR1019980708806A
Other languages
English (en)
Korean (ko)
Inventor
제임스 엠 시저
티모시 알 에스 하워드
사원트 케이 나울라
라일 엘 몰다워
Original Assignee
둘락 노먼 씨.
쉐링 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 둘락 노먼 씨., 쉐링 코포레이션 filed Critical 둘락 노먼 씨.
Publication of KR20000065178A publication Critical patent/KR20000065178A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
KR1019980708806A 1996-05-02 1997-05-01 허혈-재관류손상을치료또는예방하는방법 KR20000065178A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64185996A 1996-05-02 1996-05-02
US8/641,859 1996-05-02
PCT/US1997/006809 WO1997040849A1 (en) 1996-05-02 1997-05-01 Method for treating or preventing ischemia-reperfusion injury

Publications (1)

Publication Number Publication Date
KR20000065178A true KR20000065178A (ko) 2000-11-06

Family

ID=24574163

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980708806A KR20000065178A (ko) 1996-05-02 1997-05-01 허혈-재관류손상을치료또는예방하는방법

Country Status (9)

Country Link
EP (1) EP0906117A1 (ja)
JP (1) JP2000509073A (ja)
KR (1) KR20000065178A (ja)
AU (1) AU721943B2 (ja)
BR (1) BR9709752A (ja)
CA (1) CA2253313A1 (ja)
IL (1) IL126657A0 (ja)
NZ (1) NZ332412A (ja)
WO (1) WO1997040849A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018080276A1 (ko) * 2016-10-31 2018-05-03 사회복지법인 삼성생명공익재단 담즙산을 포함하는 허혈성 재관류 손상의 예방 또는 치료용 약학적 조성물

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113629A (en) * 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
CA2356010A1 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
US7108982B1 (en) 1999-02-19 2006-09-19 University Of Iowa Research Foundation Diagnostics and the therapeutics for macular degeneration
JP2003506016A (ja) * 1999-02-19 2003-02-18 ザ ユニヴァーシティー オブ アイオワ リサーチ ファンデーション 動脈壁破裂障害のための診断剤および治療剤
JP2006524701A (ja) * 2003-04-25 2006-11-02 ミトス・インコーポレーテッド 酸化防止剤による予防的前処置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283096B6 (sk) * 1994-07-05 2003-02-04 Steeno Research Group A/S Imunomodulátory

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018080276A1 (ko) * 2016-10-31 2018-05-03 사회복지법인 삼성생명공익재단 담즙산을 포함하는 허혈성 재관류 손상의 예방 또는 치료용 약학적 조성물
US11185553B2 (en) 2016-10-31 2021-11-30 Samsung Life Public Welfare Foundation Pharmaceutical composition for preventing or treating ischemic-reperfusion injury comprising bile acids

Also Published As

Publication number Publication date
BR9709752A (pt) 1999-08-10
NZ332412A (en) 2000-05-26
AU721943B2 (en) 2000-07-20
JP2000509073A (ja) 2000-07-18
IL126657A0 (en) 1999-08-17
AU2740597A (en) 1997-11-19
CA2253313A1 (en) 1997-11-06
WO1997040849A1 (en) 1997-11-06
EP0906117A1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
PT639079E (pt) Composicao para tratamento de doencas mediadas por interleuquina-1 e factor de necrose tumoral
JP2000507917A (ja) 持続的低用量サイトカイン注入治療
KR20110095867A (ko) 유착 치료 또는 예방용 폴리펩티드
JP2005519891A (ja) 危篤状態の患者における罹病率および死亡率を低下させる方法
SK118595A3 (en) In vitro stimulation method for production of non-keratinocyte epitel cells and growth factor of keratinocytes for therapeutic uses
US7645733B2 (en) Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
US5360790A (en) Method and formulations for the therapy of acute renal failure
RU2486196C2 (ru) Циклический белок, не содержащий остатков цистеина
KR20000065178A (ko) 허혈-재관류손상을치료또는예방하는방법
WO1993008821A1 (en) Side effect inhibitor for cancer therapy
US6086868A (en) Method for treating or preventing ischemia-reperfusion injury
CA2100720C (en) Medicinal composition comprising tcf-ii
JP2002371006A (ja) 肺線維症予防および／または進行防止剤
EP1058544B1 (en) Inhibition of tnf activity with compositions comprising heparin and soluble tnf recpetors
US4024247A (en) Composition and method of using a protein mixture derived from liver
EP0855915A2 (en) Topical composition containing amino acid in combination with either interferon or thymidine derivatives for treating viral or inflammation diseases
MXPA98008946A (en) Method of treatment or prevention of the injury caused by isquemia-reperfus
JPH083065A (ja) 肝臓障害に対する治療剤
JPH06312941A (ja) Ｈｇｆ産生促進剤
EP2089050A2 (en) Il- 17b for use in wound healing
CN1223587A (zh) 治疗或预防局部缺血－再灌注损伤的方法
WO1994004175A1 (en) Hgf production promoter
Ikemoto et al. Protective effect of thymosin fraction 5 in animals with experimentally induced uremia
Kovats et al. Increased Mortality in Septic Rats after Leupeptin Application
CZ321699A3 (cs) Použití humánního alfal-kyselého glykoproteinu k výrobě farmaceutického přípravku

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid